import { Metadata } from "next";
import Link from "next/link";
import { Header } from "@/components/sections/Header";
import { Footer } from "@/components/sections/Footer";
import { Top3Providers } from "@/components/sections/Top3Providers";
import { Card, CardContent } from "@/components/ui/card";
import { ArrowLeft, Building2, Shield, Scale, AlertCircle, CheckCircle2, FileText } from "lucide-react";

export const metadata: Metadata = {
  title: "Best Online Semaglutide Program 2025 - Compare Top Telehealth Providers | GOV Health Report",
  description:
    "Independent assessment of licensed semaglutide telehealth providers. Regulatory compliance analysis, pricing transparency evaluation, and clinical oversight verification.",
  keywords: [
    "best online semaglutide program",
    "semaglutide telehealth",
    "online Wegovy prescription",
    "semaglutide weight loss program",
    "compounded semaglutide online",
    "GLP-1 telehealth",
  ],
};

export default function BestOnlineSemaglutideProgramPage() {
  return (
    <div className="flex min-h-screen flex-col bg-[#f8f9fa]">
      <Header />
      <main className="flex-1">
        {/* Government Header Section */}
        <section className="py-8 bg-white border-b-4 border-[#ffc72c]">
          <div className="container mx-auto max-w-4xl px-4">
            <Link
              href="/"
              className="inline-flex items-center gap-2 text-[#003366] hover:text-[#004080] mb-6 transition-colors font-medium"
            >
              <ArrowLeft className="h-4 w-4" />
              Return to Home
            </Link>

            <div className="flex items-center gap-4 mb-6">
              <div className="flex h-12 w-12 items-center justify-center rounded bg-[#003366]">
                <Building2 className="h-6 w-6 text-white" />
              </div>
              <div>
                <h1 className="text-2xl font-bold text-[#003366] sm:text-3xl">
                  Semaglutide Telehealth Provider Assessment
                </h1>
                <p className="text-sm text-gray-600 mt-1">
                  Independent Regulatory Compliance Analysis • December 2025
                </p>
              </div>
            </div>

            <div className="h-1 w-24 bg-[#ffc72c] mb-6" />

            {/* Disclaimer */}
            <div className="bg-[#a31621] text-white p-4 rounded-lg mb-6">
              <div className="flex items-start gap-3">
                <AlertCircle className="h-5 w-5 flex-shrink-0 mt-0.5" />
                <div className="text-sm">
                  <strong className="block mb-1">Important Notice: NOT a Government Website</strong>
                  This is an independent health information resource providing comparative analysis of telehealth providers.
                  All assessments are based on publicly available information and documented regulatory compliance status.
                </div>
              </div>
            </div>

            <div className="bg-[#e8eef4] border-l-4 border-[#003366] p-6 rounded">
              <h2 className="text-lg font-bold text-[#003366] mb-2">Executive Summary</h2>
              <p className="text-gray-700 leading-relaxed">
                Semaglutide telehealth services must operate under strict regulatory frameworks including state medical
                board licensure, DEA registration (where applicable), and compliance with Ryan Haight Act provisions for
                controlled substance prescribing. This assessment evaluates providers based on: (1) Licensed physician
                oversight, (2) Pricing transparency, (3) Pharmacy network compliance, (4) Clinical protocol adherence,
                and (5) Patient safety mechanisms. Market analysis indicates significant variation in regulatory compliance
                and quality standards across telehealth platforms.
              </p>
            </div>
          </div>
        </section>

        {/* Top 3 Providers */}
        <Top3Providers
          title="Verified Semaglutide Telehealth Providers"
          subtitle="Independently assessed providers meeting regulatory compliance and clinical quality standards."
        />

        {/* Content Sections */}
        <section className="py-12">
          <div className="container mx-auto max-w-4xl px-4 space-y-6">
            {/* Section 1: Regulatory Compliance Framework */}
            <Card className="border-2 border-[#003366]">
              <div className="bg-[#003366] text-white px-6 py-3 flex items-center gap-2">
                <Scale className="h-5 w-5" />
                <h2 className="text-lg font-bold">Section 1: Telehealth Regulatory Requirements</h2>
              </div>
              <CardContent className="p-6 space-y-4">
                <p className="text-gray-700 leading-relaxed">
                  Legitimate semaglutide telehealth providers must satisfy multiple regulatory compliance requirements:
                </p>

                <div className="space-y-3">
                  <div className="bg-white border-2 border-[#003366] rounded-lg overflow-hidden">
                    <div className="bg-[#e8eef4] px-4 py-2 border-b-2 border-[#003366]">
                      <h3 className="font-bold text-[#003366]">Mandatory Compliance Requirements</h3>
                    </div>
                    <div className="p-4 space-y-3 text-sm">
                      <div className="border-l-4 border-[#ffc72c] pl-3">
                        <p className="font-bold text-[#003366] mb-1">1. State Medical Licensure</p>
                        <p className="text-gray-700 text-xs">
                          Prescribing physicians must hold active, unrestricted medical licenses in the patient's state
                          of residence. Interstate telemedicine requires multi-state licensure or Interstate Medical
                          Licensure Compact (IMLC) participation. Verification: State medical board public databases.
                        </p>
                      </div>

                      <div className="border-l-4 border-[#003366] pl-3">
                        <p className="font-bold text-[#003366] mb-1">2. Valid Physician-Patient Relationship</p>
                        <p className="text-gray-700 text-xs">
                          Federal and state laws require establishment of legitimate physician-patient relationship before
                          prescribing. Minimum requirements: Medical history review, clinical assessment (synchronous or
                          asynchronous per state law), documented treatment plan. Questionnaire-only services without
                          physician interaction violate medical practice standards.
                        </p>
                      </div>

                      <div className="border-l-4 border-[#003366] pl-3">
                        <p className="font-bold text-[#003366] mb-1">3. Pharmacy Network Compliance</p>
                        <p className="text-gray-700 text-xs">
                          Dispensing facilities must hold appropriate state pharmacy licenses and DEA registrations.
                          Compounding pharmacies require compliance with USP &lt;797&gt; sterile compounding standards
                          and state-specific compounding regulations. FDA-approved semaglutide (Ozempic, Wegovy, Rybelsus)
                          must be obtained through licensed wholesalers with proper distribution chain custody.
                        </p>
                      </div>

                      <div className="border-l-4 border-[#003366] pl-3">
                        <p className="font-bold text-[#003366] mb-1">4. Informed Consent Documentation</p>
                        <p className="text-gray-700 text-xs">
                          Telehealth services must obtain and document informed consent including: Treatment risks and
                          benefits, alternative therapies, off-label use disclosure (if applicable), privacy policies,
                          limitations of telemedicine medium. Consent must be obtained before prescribing, not after.
                        </p>
                      </div>

                      <div className="border-l-4 border-[#a31621] pl-3">
                        <p className="font-bold text-[#a31621] mb-1">5. Clinical Monitoring Protocols</p>
                        <p className="text-gray-700 text-xs">
                          FDA prescribing information requires monitoring for adverse events, particularly thyroid C-cell
                          tumors (boxed warning). Responsible providers implement systematic follow-up protocols, adverse
                          event reporting mechanisms, and dose escalation supervision. Absence of monitoring constitutes
                          substandard care.
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
              </CardContent>
            </Card>

            {/* Section 2: Provider Assessment Criteria */}
            <Card className="border-2 border-[#003366]">
              <div className="bg-[#003366] text-white px-6 py-3 flex items-center gap-2">
                <FileText className="h-5 w-5" />
                <h2 className="text-lg font-bold">Section 2: Quality Assessment Framework</h2>
              </div>
              <CardContent className="p-6 space-y-4">
                <p className="text-gray-700 leading-relaxed">
                  Independent provider assessment utilizes the following evaluation criteria:
                </p>

                <div className="bg-[#e8eef4] border-2 border-[#003366] rounded-lg overflow-hidden">
                  <div className="bg-[#003366] text-white px-4 py-2">
                    <h3 className="font-bold text-sm">Assessment Categories and Weighting</h3>
                  </div>
                  <div className="p-4">
                    <table className="w-full text-sm">
                      <thead className="bg-[#e8eef4]">
                        <tr>
                          <th className="px-3 py-2 text-left text-[#003366] font-bold">Category</th>
                          <th className="px-3 py-2 text-left text-[#003366] font-bold">Weight</th>
                          <th className="px-3 py-2 text-left text-[#003366] font-bold">Key Evaluation Points</th>
                        </tr>
                      </thead>
                      <tbody className="text-gray-700 text-xs">
                        <tr className="border-b border-gray-200">
                          <td className="px-3 py-3 font-medium text-[#003366]">Regulatory Compliance</td>
                          <td className="px-3 py-3">35%</td>
                          <td className="px-3 py-3">Licensure verification, DEA status, state-specific requirements</td>
                        </tr>
                        <tr className="border-b border-gray-200">
                          <td className="px-3 py-3 font-medium text-[#003366]">Clinical Protocols</td>
                          <td className="px-3 py-3">25%</td>
                          <td className="px-3 py-3">Physician interaction quality, monitoring systems, safety protocols</td>
                        </tr>
                        <tr className="border-b border-gray-200">
                          <td className="px-3 py-3 font-medium text-[#003366]">Pricing Transparency</td>
                          <td className="px-3 py-3">20%</td>
                          <td className="px-3 py-3">Clear pricing, hidden fee disclosure, insurance coordination</td>
                        </tr>
                        <tr className="border-b border-gray-200">
                          <td className="px-3 py-3 font-medium text-[#003366]">Pharmacy Standards</td>
                          <td className="px-3 py-3">15%</td>
                          <td className="px-3 py-3">NABP accreditation, compounding compliance, source verification</td>
                        </tr>
                        <tr>
                          <td className="px-3 py-3 font-medium text-[#003366]">Patient Support</td>
                          <td className="px-3 py-3">5%</td>
                          <td className="px-3 py-3">Response times, educational resources, accessibility</td>
                        </tr>
                      </tbody>
                    </table>
                  </div>
                </div>

                <div className="grid md:grid-cols-2 gap-4 mt-4">
                  <div className="bg-white border-2 border-[#003366] rounded-lg p-4">
                    <h3 className="font-bold text-[#003366] mb-3 flex items-center gap-2 text-sm">
                      <CheckCircle2 className="h-5 w-5 text-[#ffc72c]" />
                      High-Quality Provider Indicators
                    </h3>
                    <ul className="space-y-1 text-xs text-gray-700">
                      <li className="flex gap-2">
                        <span className="text-[#003366] shrink-0">✓</span>
                        <span>Synchronous physician video consultations (not questionnaire-only)</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#003366] shrink-0">✓</span>
                        <span>Transparent all-inclusive pricing published prominently</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#003366] shrink-0">✓</span>
                        <span>NABP-accredited pharmacy partnerships with verification codes</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#003366] shrink-0">✓</span>
                        <span>Documented adverse event reporting and follow-up protocols</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#003366] shrink-0">✓</span>
                        <span>Clear prescriber credentials and state licensure disclosure</span>
                      </li>
                    </ul>
                  </div>

                  <div className="bg-white border-2 border-[#a31621] rounded-lg p-4">
                    <h3 className="font-bold text-[#a31621] mb-3 flex items-center gap-2 text-sm">
                      <AlertCircle className="h-5 w-5" />
                      Red Flag Warning Signs
                    </h3>
                    <ul className="space-y-1 text-xs text-gray-700">
                      <li className="flex gap-2">
                        <span className="text-[#a31621] shrink-0">✗</span>
                        <span>No physician interaction requirement (algorithm-based approvals)</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#a31621] shrink-0">✗</span>
                        <span>Hidden fees or pricing not disclosed until after consultation</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#a31621] shrink-0">✗</span>
                        <span>Pharmacy sourcing not disclosed or unverifiable credentials</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#a31621] shrink-0">✗</span>
                        <span>No monitoring or follow-up protocols mentioned</span>
                      </li>
                      <li className="flex gap-2">
                        <span className="text-[#a31621] shrink-0">✗</span>
                        <span>Prescriber credentials not provided or unverifiable</span>
                      </li>
                    </ul>
                  </div>
                </div>
              </CardContent>
            </Card>

            {/* Section 3: Pricing Analysis */}
            <Card className="border-2 border-[#003366]">
              <div className="bg-[#003366] text-white px-6 py-3 flex items-center gap-2">
                <Shield className="h-5 w-5" />
                <h2 className="text-lg font-bold">Section 3: Cost Structure Transparency Analysis</h2>
              </div>
              <CardContent className="p-6 space-y-4">
                <p className="text-gray-700 leading-relaxed">
                  Semaglutide telehealth pricing exhibits substantial variability based on medication source and service model:
                </p>

                <div className="bg-white border-2 border-[#003366] rounded-lg overflow-hidden">
                  <div className="bg-[#e8eef4] px-4 py-2 border-b-2 border-[#003366]">
                    <h3 className="font-bold text-[#003366]">Typical Cost Structures (Monthly)</h3>
                  </div>
                  <div className="p-4 space-y-3 text-sm">
                    <div className="bg-[#e8eef4] p-3 rounded">
                      <p className="font-bold text-[#003366] mb-2">FDA-Approved Brand (Wegovy)</p>
                      <div className="grid md:grid-cols-2 gap-2 text-xs text-gray-700">
                        <div>
                          <p><strong>Cash Price:</strong> $1,300-1,600/month</p>
                          <p><strong>With Insurance:</strong> $25-200/month (coverage dependent)</p>
                        </div>
                        <div>
                          <p><strong>Consultation Fee:</strong> $49-99 (one-time or monthly)</p>
                          <p><strong>Total Monthly (Insured):</strong> $74-299</p>
                        </div>
                      </div>
                    </div>

                    <div className="bg-[#e8eef4] p-3 rounded">
                      <p className="font-bold text-[#003366] mb-2">Compounded Semaglutide</p>
                      <div className="grid md:grid-cols-2 gap-2 text-xs text-gray-700">
                        <div>
                          <p><strong>Medication Cost:</strong> $199-349/month</p>
                          <p><strong>Dose Dependent:</strong> Higher doses increase cost</p>
                        </div>
                        <div>
                          <p><strong>Consultation Fee:</strong> $0-99 (varies by provider)</p>
                          <p><strong>Total Monthly:</strong> $199-448</p>
                        </div>
                      </div>
                      <p className="text-xs text-gray-600 mt-2 italic">
                        Note: Compounded semaglutide legality requires FDA shortage designation. Verify current shortage
                        status at FDA Drug Shortages Database before purchase.
                      </p>
                    </div>

                    <div className="bg-[#e8eef4] p-3 rounded">
                      <p className="font-bold text-[#003366] mb-2">Hidden Fees to Identify</p>
                      <ul className="text-xs text-gray-700 space-y-1">
                        <li className="flex gap-2">
                          <span className="text-[#ffc72c]">●</span>
                          <span>Recurring "membership" or "platform" fees not disclosed in advertised price</span>
                        </li>
                        <li className="flex gap-2">
                          <span className="text-[#ffc72c]">●</span>
                          <span>Shipping charges added at checkout (legitimate providers include in total)</span>
                        </li>
                        <li className="flex gap-2">
                          <span className="text-[#ffc72c]">●</span>
                          <span>Required purchase of additional supplements or "support programs"</span>
                        </li>
                        <li className="flex gap-2">
                          <span className="text-[#ffc72c]">●</span>
                          <span>Non-refundable consultation fees charged before approval notification</span>
                        </li>
                      </ul>
                    </div>
                  </div>
                </div>
              </CardContent>
            </Card>

            {/* Section 4: Compounded vs FDA-Approved */}
            <Card className="border-2 border-[#003366]">
              <div className="bg-[#003366] text-white px-6 py-3 flex items-center gap-2">
                <AlertCircle className="h-5 w-5" />
                <h2 className="text-lg font-bold">Section 4: FDA-Approved vs Compounded Semaglutide</h2>
              </div>
              <CardContent className="p-6 space-y-4">
                <p className="text-gray-700 leading-relaxed">
                  Critical distinction exists between FDA-approved semaglutide products and compounded formulations:
                </p>

                <div className="grid md:grid-cols-2 gap-4">
                  <div className="border-2 border-[#ffc72c] rounded-lg overflow-hidden">
                    <div className="bg-[#ffc72c] px-4 py-2">
                      <h3 className="font-bold text-[#003366]">FDA-Approved Products</h3>
                    </div>
                    <div className="p-4 space-y-2 text-xs text-gray-700">
                      <p><strong className="text-[#003366]">Products:</strong> Ozempic (diabetes), Wegovy (weight loss), Rybelsus (oral)</p>
                      <p><strong className="text-[#003366]">Regulatory Status:</strong> FDA approval based on Phase III clinical trials demonstrating safety and efficacy</p>
                      <p><strong className="text-[#003366]">Quality Assurance:</strong> FDA-inspected manufacturing facilities, batch testing, stability data requirements</p>
                      <p><strong className="text-[#003366]">Consistency:</strong> Guaranteed potency, sterility, and purity per FDA standards</p>
                      <p><strong className="text-[#003366]">Availability:</strong> Always available when not in FDA shortage database</p>
                    </div>
                  </div>

                  <div className="border-2 border-[#003366] rounded-lg overflow-hidden">
                    <div className="bg-[#e8eef4] px-4 py-2 border-b-2 border-[#003366]">
                      <h3 className="font-bold text-[#003366]">Compounded Semaglutide</h3>
                    </div>
                    <div className="p-4 space-y-2 text-xs text-gray-700">
                      <p><strong className="text-[#003366]">Legal Basis:</strong> FDA Section 503A allows compounding during drug shortage periods only</p>
                      <p><strong className="text-[#003366]">Regulatory Status:</strong> NOT FDA-approved; exempt from FDA approval requirements under specific conditions</p>
                      <p><strong className="text-[#003366]">Quality Variability:</strong> State board of pharmacy oversight; standards vary by jurisdiction</p>
                      <p><strong className="text-[#003366]">Testing Requirements:</strong> Potency testing not federally mandated (though many perform voluntarily)</p>
                      <p><strong className="text-[#003366]">Legality Constraint:</strong> Becomes illegal when FDA removes shortage designation</p>
                    </div>
                  </div>
                </div>

                <div className="bg-[#e8eef4] border-l-4 border-[#a31621] p-4 mt-4">
                  <h3 className="font-bold text-[#a31621] mb-2 text-sm">Important Legal Considerations</h3>
                  <p className="text-xs text-gray-700 mb-2">
                    As of December 2025, FDA maintains semaglutide on the drug shortage list, permitting compounding
                    under 503A exemptions. However:
                  </p>
                  <ul className="text-xs text-gray-700 space-y-1">
                    <li className="flex gap-2">
                      <span className="text-[#a31621] shrink-0">!</span>
                      <span>When FDA removes semaglutide from shortage list, compounded versions become illegal</span>
                    </li>
                    <li className="flex gap-2">
                      <span className="text-[#a31621] shrink-0">!</span>
                      <span>Providers must cease compounding within designated grace period (typically 60 days)</span>
                    </li>
                    <li className="flex gap-2">
                      <span className="text-[#a31621] shrink-0">!</span>
                      <span>Patients on compounded formulations should have transition plan to FDA-approved products</span>
                    </li>
                  </ul>
                </div>
              </CardContent>
            </Card>

            {/* Section 5: Selection Guidance */}
            <Card className="border-2 border-[#003366]">
              <div className="bg-[#003366] text-white px-6 py-3 flex items-center gap-2">
                <CheckCircle2 className="h-5 w-5" />
                <h2 className="text-lg font-bold">Section 5: Provider Selection Decision Framework</h2>
              </div>
              <CardContent className="p-6 space-y-4">
                <p className="text-gray-700 leading-relaxed">
                  Evidence-based provider selection process:
                </p>

                <div className="space-y-3">
                  <div className="bg-[#e8eef4] border-l-4 border-[#ffc72c] p-4">
                    <h3 className="font-bold text-[#003366] mb-2 text-sm">Step 1: Verify Regulatory Compliance</h3>
                    <ul className="text-xs text-gray-700 space-y-1">
                      <li>• Check state medical board database for prescriber licensure status</li>
                      <li>• Verify pharmacy NABP accreditation at nabp.pharmacy</li>
                      <li>• Confirm provider operates in your state (verify via website or customer service)</li>
                    </ul>
                  </div>

                  <div className="bg-[#e8eef4] border-l-4 border-[#003366] p-4">
                    <h3 className="font-bold text-[#003366] mb-2 text-sm">Step 2: Assess Clinical Quality</h3>
                    <ul className="text-xs text-gray-700 space-y-1">
                      <li>• Confirm requirement for physician consultation (not automated approval)</li>
                      <li>• Review monitoring and follow-up protocols described on website</li>
                      <li>• Evaluate educational resources and patient support availability</li>
                    </ul>
                  </div>

                  <div className="bg-[#e8eef4] border-l-4 border-[#003366] p-4">
                    <h3 className="font-bold text-[#003366] mb-2 text-sm">Step 3: Compare Total Cost Transparency</h3>
                    <ul className="text-xs text-gray-700 space-y-1">
                      <li>• Calculate true monthly cost including all fees and shipping</li>
                      <li>• Verify no hidden membership or recurring charges</li>
                      <li>• Compare cost across 3+ providers before committing</li>
                    </ul>
                  </div>

                  <div className="bg-[#e8eef4] border-l-4 border-[#003366] p-4">
                    <h3 className="font-bold text-[#003366] mb-2 text-sm">Step 4: Review Terms and Policies</h3>
                    <ul className="text-xs text-gray-700 space-y-1">
                      <li>• Understand cancellation and refund policies before payment</li>
                      <li>• Review privacy policy and data handling practices</li>
                      <li>• Clarify what happens if treatment needs to stop (medication changes, side effects)</li>
                    </ul>
                  </div>
                </div>
              </CardContent>
            </Card>

            {/* Related Resources */}
            <Card className="border-2 border-[#003366]">
              <div className="bg-[#e8eef4] px-6 py-3 border-b-2 border-[#003366]">
                <h2 className="text-lg font-bold text-[#003366]">Related Clinical Resources</h2>
              </div>
              <CardContent className="p-6">
                <div className="grid gap-3 sm:grid-cols-2">
                  <Link
                    href="/best-compounding-pharmacy-for-semaglutide"
                    className="text-[#003366] hover:text-[#004080] underline text-sm"
                  >
                    → Semaglutide Compounding Pharmacy Assessment
                  </Link>
                  <Link
                    href="/best-online-tirzepatide-program"
                    className="text-[#003366] hover:text-[#004080] underline text-sm"
                  >
                    → Tirzepatide Telehealth Provider Directory
                  </Link>
                  <Link
                    href="/best-place-to-inject-semaglutide"
                    className="text-[#003366] hover:text-[#004080] underline text-sm"
                  >
                    → Semaglutide Administration Protocol
                  </Link>
                  <Link
                    href="/best-vitamins-to-take-while-on-semaglutide"
                    className="text-[#003366] hover:text-[#004080] underline text-sm"
                  >
                    → Semaglutide Supplementation Guidelines
                  </Link>
                </div>
              </CardContent>
            </Card>
          </div>
        </section>
      </main>
      <Footer />
    </div>
  );
}
